GoodRx Quarterly Income Statements Chart
Quarterly
|
Annual
GoodRx Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue | 203,070,000 | 202,970,000 | 198,583,000 | 195,251,000 | 200,610,000 | 197,880,000 | 196,644,000 | 179,958,000 | 189,677,000 | 183,986,000 | 184,109,000 | 187,318,000 | 191,798,000 | 203,329,000 | 213,256,000 | 195,102,000 | 176,635,000 | 160,431,000 | 153,544,000 | 140,453,000 |
| yoy | 1.23% | 2.57% | 0.99% | 8.50% | 5.76% | 7.55% | 6.81% | -3.93% | -1.11% | -9.51% | -13.67% | -3.99% | 8.58% | 26.74% | 38.89% | 38.91% | ||||
| qoq | 0.05% | 2.21% | 1.71% | -2.67% | 1.38% | 0.63% | 9.27% | -5.12% | 3.09% | -0.07% | -1.71% | -2.34% | -5.67% | -4.65% | 9.30% | 10.45% | 10.10% | 4.49% | 9.32% | |
| costs and operating expenses: | ||||||||||||||||||||
| cost of revenue, exclusive of depreciation and amortization presented separately below | 13,350,000 | 13,364,000 | 12,193,000 | 11,684,000 | 11,870,000 | 12,468,000 | 15,170,000 | 18,721,000 | 16,339,000 | 16,695,000 | 17,360,000 | 17,395,000 | 18,044,000 | 12,280,000 | 13,927,000 | 11,271,000 | 11,090,000 | 10,428,000 | 9,204,000 | 7,540,000 |
| product development and technology | 29,933,000 | 31,142,000 | 31,739,000 | 30,139,000 | 30,854,000 | 31,017,000 | 32,032,000 | 39,611,000 | 31,285,000 | 32,908,000 | 36,770,000 | 35,921,000 | 35,404,000 | 35,042,000 | 35,060,000 | 35,073,000 | 29,567,000 | 26,160,000 | 23,683,000 | 15,846,000 |
| sales and marketing | 84,870,000 | 84,542,000 | 93,829,000 | 89,867,000 | 93,454,000 | 89,964,000 | 93,751,000 | 91,615,000 | 77,440,000 | 78,522,000 | 84,128,000 | 86,215,000 | 94,338,000 | 92,950,000 | 106,491,000 | 95,651,000 | 88,381,000 | 79,694,000 | 74,940,000 | 65,113,000 |
| general and administrative | 28,379,000 | 29,630,000 | 23,546,000 | 25,619,000 | 27,589,000 | 41,108,000 | 30,371,000 | 35,317,000 | 30,208,000 | 29,619,000 | 28,581,000 | 49,548,000 | 34,740,000 | 31,923,000 | 35,374,000 | 35,947,000 | 39,579,000 | 43,786,000 | 340,753,000 | 108,479,000 |
| depreciation and amortization | 19,729,000 | 20,912,000 | 19,096,000 | 17,535,000 | 16,965,000 | 15,942,000 | 43,608,000 | 33,024,000 | 16,097,000 | 14,939,000 | 15,533,000 | 13,952,000 | 13,319,000 | 11,373,000 | 10,648,000 | 10,161,000 | 8,369,000 | 5,361,000 | 4,404,000 | 5,160,000 |
| total costs and operating expenses | 176,261,000 | 179,590,000 | 180,403,000 | 174,844,000 | 180,732,000 | 190,499,000 | 214,932,000 | 218,288,000 | 171,369,000 | 172,683,000 | 182,372,000 | 203,031,000 | 195,845,000 | 183,568,000 | 201,500,000 | 188,103,000 | 176,986,000 | 165,429,000 | 452,984,000 | 202,138,000 |
| operating income | 26,809,000 | 23,380,000 | 18,180,000 | 20,407,000 | 19,878,000 | 7,381,000 | -18,288,000 | -38,330,000 | 18,308,000 | 11,303,000 | 1,737,000 | -15,713,000 | -4,047,000 | 19,761,000 | 11,756,000 | 6,999,000 | -351,000 | -4,998,000 | -299,440,000 | -61,685,000 |
| yoy | 34.87% | 216.76% | -199.41% | -153.24% | 8.58% | -34.70% | -1152.85% | 143.94% | -552.38% | -42.80% | -85.22% | -324.50% | 1052.99% | -495.38% | -103.93% | -111.35% | ||||
| qoq | 14.67% | 28.60% | -10.91% | 2.66% | 169.31% | -140.36% | -52.29% | -309.36% | 61.97% | 550.72% | -111.05% | 288.26% | -120.48% | 68.09% | 67.97% | -2094.02% | -92.98% | -98.33% | 385.43% | |
| operating margin % | 13.20% | 11.52% | 9.15% | 10.45% | 9.91% | 3.73% | -9.30% | -21.30% | 9.65% | 6.14% | 0.94% | -8.39% | -2.11% | 9.72% | 5.51% | 3.59% | -0.20% | -3.12% | -195.02% | -43.92% |
| other income, net: | ||||||||||||||||||||
| other income | 694,000 | -2,660,000 | -2,200,000 | -1,808,000 | -2,000 | 1,000 | ||||||||||||||
| interest income | 2,803,000 | 3,932,000 | 4,587,000 | 4,797,000 | 6,334,000 | 7,555,000 | 8,474,000 | 8,649,000 | 7,814,000 | 7,234,000 | 13,103,000 | -2,920,000 | -857,000 | -52,000 | -17,000 | -13,000 | -13,000 | -16,000 | -20,000 | -24,000 |
| interest expense | -10,729,000 | -10,644,000 | -11,358,000 | -12,355,000 | -14,566,000 | -14,643,000 | -14,821,000 | -14,720,000 | -14,054,000 | -13,133,000 | -56,559,000 | 9,478,000 | 6,969,000 | 5,869,000 | 5,903,000 | 5,928,000 | 5,906,000 | 5,905,000 | 6,216,000 | 6,264,000 |
| total other income | -7,232,000 | -6,712,000 | -6,771,000 | -12,295,000 | -8,232,000 | -7,088,000 | -6,347,000 | -8,271,000 | -6,240,000 | -7,707,000 | -43,456,000 | 6,558,000 | 6,112,000 | 5,817,000 | 5,886,000 | 5,915,000 | 5,893,000 | 5,889,000 | 6,194,000 | 6,241,000 |
| income before income taxes | 19,577,000 | 16,668,000 | 11,409,000 | 8,112,000 | 11,646,000 | 293,000 | -24,635,000 | -46,601,000 | 12,068,000 | 3,596,000 | -4,745,000 | -22,271,000 | -10,159,000 | 13,944,000 | 5,870,000 | 1,084,000 | -6,244,000 | -10,887,000 | ||
| income tax expense | -6,734,000 | -5,616,000 | -1,302,000 | -6,886,000 | ||||||||||||||||
| net income | 12,843,000 | 11,052,000 | 6,740,000 | 3,965,000 | 6,694,000 | -1,009,000 | -25,869,000 | -38,495,000 | 58,786,000 | -3,290,000 | -1,972,000 | -41,734,000 | -1,415,000 | 12,293,000 | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -298,274,000 | -50,032,000 |
| yoy | 91.86% | -1195.34% | -126.05% | -110.30% | -88.61% | -69.33% | 1211.82% | -7.76% | -4254.49% | -126.76% | -95.06% | 130.97% | -104.56% | 636.99% | -86.62% | -63.89% | ||||
| qoq | 16.21% | 63.98% | 69.99% | -40.77% | -763.43% | -96.10% | -32.80% | -165.48% | -1886.81% | 66.84% | -95.27% | 2849.40% | -111.51% | -130.80% | 120.90% | -158.17% | 1762.17% | -100.56% | 496.17% | |
| net income margin % | 6.32% | 5.45% | 3.39% | 2.03% | 3.34% | -0.51% | -13.16% | -21.39% | 30.99% | -1.79% | -1.07% | -22.28% | -0.74% | 6.05% | -18.72% | -9.26% | 17.58% | 1.04% | -194.26% | -35.62% |
| earnings per share: | ||||||||||||||||||||
| basic | 0.04 | 0.03 | 0.01 | 0.01 | 0.02 | 0.01 | -0.09 | 0.14 | -0.01 | -0.018 | -0.1 | 0 | 0.03 | -0.1 | -0.04 | 0.08 | ||||
| diluted | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 | 0.01 | -0.09 | 0.14 | -0.01 | -0.018 | -0.1 | 0 | 0.03 | -0.09 | -0.04 | 0.07 | ||||
| weighted-average shares used for eps calculation | ||||||||||||||||||||
| basic | 356,623 | 379,196 | 385,737 | 379,667 | 376,254 | 413,437 | 412,221 | 412,429 | 412,956 | 412,135 | 414,739 | 409,981 | 411,223 | 408,363 | 406,170 | 274,696 | 241,061 | |||
| diluted | 357,159 | 379,656 | 392,172 | 388,504 | 384,732 | 413,437 | 414,335 | 412,429 | 412,956 | 412,135 | 427,378 | 409,981 | 411,223 | 428,867 | 429,577 | 274,696 | 241,061 | |||
| stock-based compensation included in costs and operating expenses: | ||||||||||||||||||||
| cost of revenue | 122 | 100 | 94 | 86 | 64 | 76 | 123 | 146 | 180 | 161 | 169 | 136 | 100 | -46 | 258 | 238 | 181 | 121 | 86 | 57 |
| gross profit | 203,069,878 | 202,969,900 | 198,582,906 | 195,250,914 | 200,609,936 | 197,879,924 | 196,643,877 | 179,957,854 | 189,676,820 | 183,985,839 | 184,108,831 | 187,317,864 | 191,797,900 | 203,328,954 | 213,255,742 | 195,101,762 | 176,634,819 | 160,430,879 | 153,543,914 | 140,452,943 |
| yoy | 1.23% | 2.57% | 0.99% | 8.50% | 5.76% | 7.55% | 6.81% | -3.93% | -1.11% | -9.51% | -13.67% | -3.99% | 8.58% | 26.74% | 38.89% | 38.91% | ||||
| qoq | 0.05% | 2.21% | 1.71% | -2.67% | 1.38% | 0.63% | 9.27% | -5.12% | 3.09% | -0.07% | -1.71% | -2.34% | -5.67% | -4.65% | 9.30% | 10.45% | 10.10% | 4.49% | 9.32% | |
| gross margin % | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| loss on extinguishment of debt | -2,077,000 | |||||||||||||||||||
| income tax benefit | -4,669,000 | -4,147,000 | -4,952,000 | -1,234,000 | 8,106,000 | 46,718,000 | 2,773,000 | -19,463,000 | 8,744,000 | -1,651,000 | -45,784,000 | -19,153,000 | 37,305,000 | 12,555,000 | 7,360,000 | 17,894,000 | ||||
| loss per share: | ||||||||||||||||||||
| basic and diluted | 0 | |||||||||||||||||||
| weighted-average shares used for eps calculation | ||||||||||||||||||||
| basic and diluted | 390,048 | 410,315 | 412,858 | |||||||||||||||||
| net income attributable to common stockholders: | ||||||||||||||||||||
| basic | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,668,000 | -50,032,000 | ||||||||||||||
| diluted | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,715,000 | -50,032,000 | ||||||||||||||
| net income attributable to common stockholders | ||||||||||||||||||||
| basic | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,668,000 | -50,032,000 | ||||||||||||||
| diluted | -39,914,000 | -18,069,000 | 31,061,000 | 1,668,000 | -296,715,000 | -50,032,000 | ||||||||||||||
| earnings per share: | ||||||||||||||||||||
| earnings per share - basic | 0 | -1.08 | -0.21 | |||||||||||||||||
| earnings per share - diluted | 0 | -1.08 | -0.21 | |||||||||||||||||
| other income: | ||||||||||||||||||||
| income before income tax expense | 546,000 | -67,926,000 |
We provide you with 20 years income statements for GoodRx stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GoodRx stock. Explore the full financial landscape of GoodRx stock with our expertly curated income statements.
The information provided in this report about GoodRx stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.